Magic mushrooms might be key to quelling depression among people battling cancer. A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with major depression, according to small-scale study published June 16 in the journal Cancer. “One dose of psilocybin with psychological support to treat depression has a long-term positive impact on relieving depression for as much as two years for a substantial portion of patients with cancer, and we’re exploring whether repeating the treatment resolves depression for more than half of the patients,” lead researcher Dr. Manish Agrawal, CEO and co-founder of Sunstone Therapies, said in a news release. About 25% of people living with cancer have depression severe enough it can impact their odds of survival, researchers said in background notes. For the phase 2 clinical trial, 28 patients with cancer and major depression took a single 25-milligram dose of psilocybin while being guided by a therapist. Psilocybin is the active ingredient in magic mushrooms. Two years later, about half of the patients had significant and sustained reduction in their depression symptoms, results show. For a quarter of the patients, their sustained reduction in depression did not require any additional psychedelic or antidepressant medications, researchers said. About 43% also had sustained reduction of anxiety symptoms, researchers added. Previous research has noted that these sort of positive benefits… read on > read on >

















